Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
MELBOURNE, AustraliaandSAN FRANCISCO, March 27, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ( Alterity or the Company ), a biotechnology company...